A new FDA-approved
CDx for NSCLC Know EARLY the PD-L1 status for NSCLC patients with the VENTANA PD-L1 (SP263) Assay
CDx for NSCLC Know EARLY the PD-L1 status for NSCLC patients with the VENTANA PD-L1 (SP263) Assay
Download the free VENTANA PD-L1 (SP263) Interpretation Guide to aid in clinical evaluation and scoring with this new assay.
All fields required
All fields required
